BPMX - BioPharmX Corporation

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.37M
Enterprise Value 32.23M
Trailing P/E N/A
Forward P/E 1-0.39
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)112.01
Price/Book (mrq)3.01
Enterprise Value/Revenue 357.17
Enterprise Value/EBITDA 6-0.14

Trading Information

Stock Price History

Beta (3Y Monthly) 0.23
52-Week Change 3-93.15%
S&P500 52-Week Change 36.34%
52 Week High 36.7500
52 Week Low 30.4000
50-Day Moving Average 30.6938
200-Day Moving Average 31.8165

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 3519.42k
Shares Outstanding 5N/A
Float 9.75M
% Held by Insiders 11.64%
% Held by Institutions 118.95%
Shares Short (Jun 28, 2019) 4486.91k
Short Ratio (Jun 28, 2019) 40.32
Short % of Float (Jun 28, 2019) 44.98%
Short % of Shares Outstanding (Jun 28, 2019) 44.56%
Shares Short (prior month May 31, 2019) 4522.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 225/1
Last Split Date 3Apr 26, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jan 31, 2019
Most Recent Quarter (mrq)Apr 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-39,873.08%

Management Effectiveness

Return on Assets (ttm)-118.76%
Return on Equity (ttm)-341.50%

Income Statement

Revenue (ttm)39k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-26k
EBITDA -15.49M
Net Income Avi to Common (ttm)-16.48M
Diluted EPS (ttm)-1.9880
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.28M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)1.22M
Total Debt/Equity (mrq)85.39
Current Ratio (mrq)1.40
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-14.72M
Levered Free Cash Flow (ttm)-8.75M